Completed PHASE4 INTERVENTIONAL 2-arm NCT01486563

Hydroxyethyl Starch and Renal Function After Radical Prostatectomy (VORA)

Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy

Sponsor: Regional Hospital Holstebro

Conditions Prostate Cancer

Interventions Sodium Chloride 9 mg/ml Voluven (Hydroxyethyl starch 130/0,4)

Updated 5 times since 2017 Last updated: Sep 16, 2013 Started: Jan 31, 2012 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Prostate Cancer and is currently completed. Regional Hospital Holstebro leads this study, which shows 5 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Regional Hospital Holstebro

Data source: Regional Hospital Holstebro

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Holstebro, Denmark